ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
CP019226_673 # 686794 # 687894 # 1 # ID=1_673;partial=00;start_type=GTG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.682	CP019226_673	686794	687894	+	Strict	175	176.792	vanT gene in vanG cluster	33.63	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGCGTCCTGCGCAAGCGTCGATCGATCTGGAGGCGTTGCGCCACAACTACCGCCTGGCCAAGCGCCTGGGTGGCAGCAAGGCGCTGGCGGTGGTCAAGGCCGATGCTTACGGGCATGGCGCAGTGCGTTGCGCGCAGGCGCTGGAACCGGAGGCCGATGGCTTCGCGGTGGCCTGCATCGAAGAGGCGCTGGAACTGCGCCAGGCCGGCATCCGCGCGCCAATCCTGTTGCTGGAAGGGTTCTTCGAGCACGACGAGCTGCGCCTGATCGCCGAGCACGACCTGTGGACGGTGGCGGCTACGCCGCAACAGGTGCGCGCGCTGGCCGCGTTCCAGAGCCCACGACCGTTGCGGGTGTGGTTGAAGATGGATAGCGGCATGCATCGGCTGGGCCTGTCGCCGGAAGACTTCCGCGCCGCATGGCTGCGCCTGTGCGGGCTGCCGCAGATCGCCTCGCTGGTGCTGATGACCCACCTGGCGCGCGCCGACGAATTGGACTGCAGCCGCACCGACGAACAGGCGGTGGCCTTTGCGCTGAGCGCCGGCGGCATGCGCGCGGAAACCAGTCTGCGCAATTCGCCCGGCCTGCTCGGCTGGCCGGCGCTGCGCAACGACTGGTCGCGCCCGGGGCTGATGTTGTACGGCGCCAACCCGTTCCCGCAGGACACCGAGAACACTGCGCAATTGCGCCCGGTGATGACGCTGCGCTCGCGCATCATTTTGGTCCGCGACCTGCCGGTCGGCGAACCGGTGGGCTATGGTGCCCGTTTTGTCGCCGAACGACCGACCCGCGTCGGCGTGGTGGCGATGGGCTATGCCGACGGCTACCCGCAGTTCGCGCCGAACGGCACCCCGGTGCTGGTGGATGGCCAGGTCTGCCCATTGATCGGTCGCGTCTCGATGGACATGCTCACCGTGGACCTTACCGACCACCCGCAGGCCGCCATTGGTGCCACCGTGCAGCTGTGGGGCCAGGCACCACGCGTTGGCCCACTGGCCACGCAATGCAATGTCAGCGCGTATCAGCTGTTGTGTGGACTCAAGCGCGTGCCGCGGACGTATGTGGGTAGTGCGGCAGTGGGCGAGGTTGCAGCGCGGTAA	MRPAQASIDLEALRHNYRLAKRLGGSKALAVVKADAYGHGAVRCAQALEPEADGFAVACIEEALELRQAGIRAPILLLEGFFEHDELRLIAEHDLWTVAATPQQVRALAAFQSPRPLRVWLKMDSGMHRLGLSPEDFRAAWLRLCGLPQIASLVLMTHLARADELDCSRTDEQAVAFALSAGGMRAETSLRNSPGLLGWPALRNDWSRPGLMLYGANPFPQDTENTAQLRPVMTLRSRIILVRDLPVGEPVGYGARFVAERPTRVGVVAMGYADGYPQFAPNGTPVLVDGQVCPLIGRVSMDMLTVDLTDHPQAAIGATVQLWGQAPRVGPLATQCNVSAYQLLCGLKRVPRTYVGSAAVGEVAAR	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	51.40	gnl|BL_ORD_ID|1522|hsp_num:0	1561			1032	2028	vancomycin
CP019226_1143 # 1149796 # 1150593 # -1 # ID=1_1143;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.664	CP019226_1143	1149796	1150593	-	Strict	50	63.929	vanY gene in vanM cluster	32.12	3002961	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanY; glycopeptide resistance gene cluster	ATGCGCAATTGCCCACGTCTGCTCCTCAATACCAGCACGATCGAACTGTGGCCGGCCGATCTGTTGCGCGCGCGCGGCAACGCGGATGCGCGCGTGCTGGCGCAGGCCGATTGGCTATTGCGACGTAAGCGCGATGGGCGCTATCTGGCGGCGCATCTGCCACAAGGCATGATGCCGTTGATCCCGCGGCTGGCACGCGAGCCGGGCCTGGATGACGCGTTGGACCGTCTGCAGACCGCCAGTGGCCGCGCCGGCCAAGTCCTCGACGACGTGCTTGCGATCGACGGATTGCAGCGCCGACTGAGCCAACTGGGACTCGCTGCAAACGACTATGCTGAGCAGACCGGTCTGCAACTGATCGCCGAACCGGTTGCCCTGCAGTTTGGCGGGCGCGATCGCTTCGGTCGTCCGCTGTGGCTCAGTGCCGGCGCTGCGCGTGCATGGCGACAGCTGCGCGCGGCTGCGCTGCGCGCGGACATCGTGCTCGATGCGATCTCCGGCTACCGCAGCCACGACTACCAACTGGGCATCTTCGAGCGCAAGCGCGCGCGCGGGCTCACCCTTGAGCAGATTCTGGCGGTCAACGCCGCGCCAGGTTTCAGCGAACATCACAGCGGCGACGCCCTGGACATCGGCACACCGGGCGAACCGCCGGCCGAGGAATCCTTCGCAACCACGCCTGCATTCGCCTGGTTGCGCAACAACGCGAACGCGTTCGGCTACCGCCTGAGTTATCCACGCGACAACCCGCATGGCATCGTCTACGAGCCGTGGCACTGGCGTTGGTCGGCAGCGTAA	MRNCPRLLLNTSTIELWPADLLRARGNADARVLAQADWLLRRKRDGRYLAAHLPQGMMPLIPRLAREPGLDDALDRLQTASGRAGQVLDDVLAIDGLQRRLSQLGLAANDYAEQTGLQLIAEPVALQFGGRDRFGRPLWLSAGAARAWRQLRAAALRADIVLDAISGYRSHDYQLGIFERKRARGLTLEQILAVNAAPGFSEHHSGDALDIGTPGEPPAEESFATTPAFAWLRNNANAFGYRLSYPRDNPHGIVYEPWHWRWSAA	MVFQGNLLLVNNEYPVLEESIKTDVVNLFKHDELTKGYELLNREIYLSEKVAREFSEMVDAAEKEGVRHFSINSGFRNFDEQNALYQEMGSDYALPAGYSEHNLGLALDIGSTQMEMSEAPEGKWLEDNAWEYGFILRYPMDKTAITGIQYEPWHFRYVGLPHSAIIEEKNFALEEYLDFLKEQKSISGTIHGENYEISYYPITEKTDIEMPANLHYEISGNNMDGVIVTVYR	113.73	gnl|BL_ORD_ID|1673|hsp_num:0	1713			108	474	vancomycin; teicoplanin
CP019226_1440 # 1476800 # 1476934 # -1 # ID=1_1440;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.519	CP019226_1440 	1476800	1476934	-	Strict	700	21.1718	CMY-78	100.0	3002091	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGTTAACAGGCCTTAGTTGTCGCATCCCGGACGATGGCATAGATCCCAAACGCTATCCACTCTTCATGGCCCAAGTCGTCTTGCAGGAGTTGATAGAGTCCCTGCAATGGACTCCGGGAGCCAAGCCATGCTGA	MLTGLSCRIPDDGIDPKRYPLFMAQVVLQELIESLQWTPGAKPC	MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPGDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ	11.55	gnl|BL_ORD_ID|1505|hsp_num:0	1634	True	loose hit with at least 95 percent identity pushed strict	480	501	
